Product Information

GABAPENTIN 100 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0209 per EA under NDC 67877022210. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 17, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 100 MG CAPSULE

Gabapentin
$0.0209per EA

Strength

100 mg/1

NDC

67877022210

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090858

FDA Approved

12/17/2010

TE Code

AB

On Market Since

1/29/2011

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 100 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0426 (Feb 12, 2014)
All-time low$0.0186 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0208
Median price$0.0290
Average price$0.0291
Largest weekly change+24.9% (Jul 18, 2018)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+1.0%

1M

-0.1%

3M

-1.0%

6M

-1.4%

1Y

-5.1%

3Y

-16.8%

5Y

-32.1%

All

-38.9%

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0209 per EA (NDC 67877022210), effective Aug 19, 2026.

How has the price of GABAPENTIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 38.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?

Since Nov 28, 2013, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0186 (Nov 20, 2024) to a high of $0.0426 (Feb 12, 2014), with a median of $0.0290 per EA.

Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?

17 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 100 MG CAPSULE?

GABAPENTIN 100 MG CAPSULE (NDC 67877022210) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.